Surrogate Mothers Face Increased Risks of Hypertension, Bleeding and Preterm Birth: Study
More research is needed to understand why surrogate mothers face higher risks of pregnancy and birth related complications.
More research is needed to understand why surrogate mothers face higher risks of pregnancy and birth related complications.
Judge hopes Valsartan recall lawsuit sanctions over discovery failures will serve as a deterrent to other foreign companies considering disregard for U.S. laws.
A joint report recommends that the first valsartan recall lawsuit be set to go before a jury in Fall 2024, after a prior trial scheduled to begin in March was postponed when the judge presiding over the litigation retired.
Concerns about pregnancy side effects of prescription medications may be contributing to about 40% of pregnant women with hypertension not receiving drug treatments.
Lawyers will seek preliminary approval for a settlement of valsartan lawsuits against the generic drug maker Hetero, but claims involving other manufacturers of contaminated valsartan pills remain unresolved
The findings add to growing concerns over the widespread use of hypertension drugs, since the threshold for what counts as high blood pressure was lowered in 2017.
Parties indicate they have reached a proposed settlement agreement for certain Valsartan class action lawsuits and claims involving a similar drug, irbesartan.
Patients with dementia face triple the risk of nursing home falls and fractures when starting blood pressure medication treatment, researchers warn.
Xarelto and Eliquis have already been linked to increased bleeding risks, which the new study says could be made worse by some hypertension drugs commonly prescribed as an atrial fibrillation combination therapy
The first valsartan recall lawsuit was scheduled to go to trial late last month, but the case was delayed and a new date has not yet been announced.